Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$27,000.00

The role of TGF-ß in human regulatory T cell development and function

EF 2024-25

Résumé
Regulatory T cells (Tregs) are a type of immune cell that help control immune responses and are required to prevent autoimmune and inflammatory diseases. As Tregs can precisely suppress specific immune responses, Treg cell therapy is a desirable alternative to pharmaceutical immunosuppressants which tend to suppress broad areas of the immune system, increasing patients risk for infections and cancer. To date, Treg cell therapies are mainly being developed for autoimmune disease and transplant recipients. While the role of Tregs in immune suppression is well-established, the specific mechanisms and molecules involved in Treg development and function remain unclear. Our group is developing a Treg cell therapy using Tregs from the thymus, the site of human T cell development. As this organ blocks access to the heart in infants, thymus tissue is removed during pediatric heart surgery, granting us with an ample source of Tregs. My project will explore the role of transforming growth factor-b (TGF-B), a molecule associated with Treg differentiation and function. I will first isolate Tregs from human thymuses and expand them with and without TGF-B. I will assess these Tregs using in vitro assays to examine markers for Treg identity and suppressive function and in vivo mouse models to measure their ability to protect from inflammatory disease. Using gene editing methods, I will delete the gene for TGF-B in human Tregs to inhibit their TGF-B production and examine whether in vitro and in vivo Treg suppressive function is altered. My project will clarify the role of a complex, multifunctional molecule in Treg biology as well as help inform strategies to optimize Treg function. The latter has important implications for Treg therapies to ensure safety and maximize effectiveness.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530139
Name
Lao Dana L
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of TGF-ß in human regulatory T cell development and function
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autoimmunity; Cell Therapy; Graft-Versus-Host Disease; Immune Tolerance; Immunology; Inflammatory Diseases; Regulatory T Cells; Transplantation
Abstract
Regulatory T cells (Tregs) are a type of immune cell that help control immune responses and are required to prevent autoimmune and inflammatory diseases. As Tregs can precisely suppress specific immune responses, Treg cell therapy is a desirable alternative to pharmaceutical immunosuppressants which tend to suppress broad areas of the immune system, increasing patients risk for infections and cancer. To date, Treg cell therapies are mainly being developed for autoimmune disease and transplant recipients. While the role of Tregs in immune suppression is well-established, the specific mechanisms and molecules involved in Treg development and function remain unclear. Our group is developing a Treg cell therapy using Tregs from the thymus, the site of human T cell development. As this organ blocks access to the heart in infants, thymus tissue is removed during pediatric heart surgery, granting us with an ample source of Tregs. My project will explore the role of transforming growth factor-b (TGF-B), a molecule associated with Treg differentiation and function. I will first isolate Tregs from human thymuses and expand them with and without TGF-B. I will assess these Tregs using in vitro assays to examine markers for Treg identity and suppressive function and in vivo mouse models to measure their ability to protect from inflammatory disease. Using gene editing methods, I will delete the gene for TGF-B in human Tregs to inhibit their TGF-B production and examine whether in vitro and in vivo Treg suppressive function is altered. My project will clarify the role of a complex, multifunctional molecule in Treg biology as well as help inform strategies to optimize Treg function. The latter has important implications for Treg therapies to ensure safety and maximize effectiveness.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lao, Dana L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~